Product logins

Find logins to all Clarivate products below.


: Mainland China

Here you will find relevant articles and insight into all Clarivate related products and news.

What a string of semaglutide biosimilars could mean for Mainland China What a string of semaglutide biosimilars could mean for Mainland China
Blog May 14, 2024
What a string of semaglutide biosimilars could mean for Mainland China
Mainland China Pharma Portfolio strategy
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
Clinical trials Mainland China Oncology
Seven RNA technology companies to keep an eye on Seven RNA technology companies to keep an eye on
Blog November 8, 2022
Seven RNA technology companies to keep an eye on
Clinical research Clinical trials COVID-19
ESMO 2022: Ten key takeaways on Europe's top oncology event ESMO 2022: Ten key takeaways on Europe's top oncology event
Blog October 10, 2022
ESMO 2022: Ten key takeaways on Europe's top oncology event
Clinical research Mainland China Market Access
Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022 Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Blog June 23, 2022
Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Clinical research Clinical trials Drugs to Watch
Top oncology breakthroughs shared at ESMO 2021 Top oncology breakthroughs shared at ESMO 2021
Blog October 7, 2021
Top oncology breakthroughs shared at ESMO 2021
Clinical trials drugstowatch2021 Mainland China
Blog February 15, 2021
Mainland China’s anticipated biosimilar boom – potential and key drivers of the market
Epidemiology Mainland China Market Access

Mainland China

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
What a string of semaglutide biosimilars could mean for Mainland China What a string of semaglutide biosimilars could mean for Mainland China
Blog May 14, 2024
What a string of semaglutide biosimilars could mean for Mainland China
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
Seven RNA technology companies to keep an eye on Seven RNA technology companies to keep an eye on
Blog November 8, 2022
Seven RNA technology companies to keep an eye on
ESMO 2022: Ten key takeaways on Europe's top oncology event ESMO 2022: Ten key takeaways on Europe's top oncology event
Blog October 10, 2022
ESMO 2022: Ten key takeaways on Europe's top oncology event
Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022 Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Blog June 23, 2022
Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Top oncology breakthroughs shared at ESMO 2021 Top oncology breakthroughs shared at ESMO 2021
Blog October 7, 2021
Top oncology breakthroughs shared at ESMO 2021
Blog February 15, 2021
Mainland China’s anticipated biosimilar boom – potential and key drivers of the market